Universitätsklinikum Schleswig-Holstein (UKSH)

Differentiated antiplatelet therapy for acute coronary syndromes (2014) Schaefer A, Arntz HR, Boudriot E, Garlichs C, Hoffmann S, Ince H, Klingenheben T, et al. Journal article Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia (2014) Meissner B, Bartram T, Eckert C, Trka J, Panzer-Grümayer R, Hermanova I, Ellinghaus E, et al. Journal article Skin irritability to sodium lauryl sulfate is associated with increased positive patch test reactions (2014) Schwitulla J, Brasch J, Löffler H, Schnuch A, Geier J, Uter W Journal article Effectiveness and tolerability of ipilimumab: experiences from 198 patients included in a named-patient program in various daily-practice settings and multiple institutions (2014) Eigentler TK, Schlaak M, Hassel JC, Loquai C, Stoffels I, Gutzmer R, Paetzold S, et al. Journal article Microsurgical training in Germany - results of a survey among trainers and trainees (2014) Kolbenschlag J, Gehl B, Daigeler A, Kremer T, Hirche C, Vogt PM, Horch RE, et al. Journal article Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV (2014) Hehlmann R, Müller MC, Lauseker M, Hanfstein B, Fabarius A, Schreiber A, Proetel U, et al. Journal article PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer (2014) Loibl S, Von Minckwitz G, Schneeweiss A, Paepke S, Lehmann A, Rezai M, Zahm DM, et al. Journal article Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension" (2014) Mahfoud F, Ukena C, Schmieder R, Cremers B, Rump LC, Vonend O, Weil J, et al. Journal article Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44) (2014) Gerber B, Von Minckwitz G, Eidtmann H, Rezai M, Fasching P, Tesch H, Eggemann H, et al. Journal article Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro) (2014) Von Minckwitz G, Rezai M, Fasching P, Huober J, Tesch H, Bauerfeind I, Hilfrich J, et al. Journal article